BenjaminNathanielUngarMD

Dermatologist

Dr. Ungar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Ruxolitinib in Seborrheic Dermatitis Start of enrollment: 2022 Nov 15
Completed
Phase 2
Roles: Contact, Principal Investigator
PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular Rosacea Start of enrollment: 2023 Jul 19
ACTIVE_NOT_RECRUITING
PHASE2
Roles: Contact, Principal Investigator
Dupilumab in the Treatment of Pediatric Alopecia Areata Start of enrollment: 2024 Jul 11
RECRUITING
PHASE2
Roles: Contact

PubMed

Low-dose oral minoxidil in a case of short anagen syndrome.
Divija Sharma, Serena Morsia, Benjamin Ungar
The Journal of Dermatological Treatment. 2025-12-01
3 citations
A phase 2a trial of brepocitinib for cicatricial alopecia.
Eden David, Neda Shokrian, Ester Del Duca, Marguerite Meariman, Celina Dubin
Journal of the American Academy of Dermatology. 2025-03-01
Changes in patient sentiment on Reddit through periods of atopic dermatitis treatment.
Andrew K Yang, Camille M Powers, Hannah Verma, Divija Sharma, Austin J Piontkowski
Clinical and Experimental Dermatology. 2025-02-24

Odds for Poor Alopecia Areata Outcomes High with Comorbid Asthma or Atopic DermatitisJanuary 24th, 2025
Inflammation Now the Key Target for Seborrheic DermatitisJanuary 6th, 2025
Dupilumab Effective for Atopic Dermatitis in Young Children with, Without ComorbiditiesDecember 16th, 2024
Join now to see all